2024-01-31
Cancer patients often undergo extensive treatments, including surgeries, chemotherapy, and immunotherapy, which make them more susceptible to infections. Many cancer patients therefore rely on effective antibiotics to keep opportunistic infections at bay. On this World Cancer Day we invite cancer communities and organizations worldwide to join our call on governments to make the United Nations High-Level Meeting on AMR in September this year the turning point that is urgently needed in the global response to antibiotic resistance.
The active engagement of the global cancer community in addressing antibiotic resistance can facilitate the development of tailored strategies for infection prevention and treatment in cancer care, taking into account the specific needs of individuals with compromised immune systems. Moreover, collaboration with the cancer community fosters awareness, education, and advocacy, promoting responsible antibiotic use and infection control practices.
Towards the UN High level meeting on AMR in September, raising the voices of the groups most affected by antibiotic resistance will be an important factor in increasing demands for action of governments from below.
ReAct Interview
Dr. Honar Cherif: My patients can receive 5-10 courses of antibiotics during their cancer treatment
Interesting reads: Cancer and antibiotic resistance
ReAct Policy Brief: Successful cancer treatment relies on effective antibiotics
Virtual Dialogue: Cancer patients are the primary victims of the superbug crisis
Webinar: Listen to Sonali Johnson, Head of Knowledge, Advocacy & Policy, UICC
– keynote during ReAct, Antibiotic Smart Sweden and Uppsala Antibiotic Center’s community engagement webinar.
World Cancer Day: Cancer patients rely on effective antibiotics
Blog post: Could the best chemotherapy be an antimicrobial drug?
More from "2024"
- ReAct’s statement at UN High-Level meeting on AMR
- ReAct partners with ITN Business to improve equitable access to effective antibiotics
- New study: Antibiotic resistance could cause nearly 40 million deaths by 2050
- ReAct statement on the final version of the Political Declaration on AMR
- Opinion: The world’s response to antibiotic resistance is still too weak
- International Meeting “Mother Earth, One Health”: A commitment to life
- Latest version of UN High-Level Meeting Political Declaration disappoints in crucial places
- ReAct Asia Pacific AMR Conference
- Open letter to Ms Amina J Mohammed
- Key takeaways from LMIC roundtable on global governance on antibiotic resistance
- Wold Microbiome Day 2024: Dialogue on alternative to war metaphor in medicine
- ReAct Asia Pacific engages students and teachers in the fight against antibiotic resistance
- Growing support for the ‘From People to Leaders’ campaign!
- The Global Campaign From People to Leaders: Support from 97 communities and civil society groups!
- Community engagement report Asia Pacific
- Reflections from a week where stakeholders took the stage in New York
- ReAct’s Impact Report 2023!
- Cancer, antimicrobial resistance and community engagement
- People’s Health Assembly, Argentina
- ABR and AMR
- ReAct receives additional financial support from Sweden
- AMR must remain an important piece in the Pandemic Agreement puzzle
- Rocky start for the UN High level meeting on AMR
- ReAct Africa and LifeArc launch the ASPIRE initiative for stronger action on antimicrobial resistance
- UN High Level Meeting on AMR: Countdown begins
- ReAct Latin America Dialogue Series
- ReAct expands its work
- New Report Community Engagement
- World Cancer Day: Cancer communities can help making the UN High Level meeting on AMR a turning point
- Handbook for Antibiotic Smart Communities Framework
- Dr. S.S. Lal appointed new Director for ReAct Asia Pacific!